Results 191 to 200 of about 371,827 (350)

Table TS1 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas

, 2023
Xin Gao, Nermin Kady, Chenguang Wang, Suhaib Abdelrahman, Peter H. Gann, Maria Sverdlov, Ashley Wolfe, Noah A. Brown, John Reneau, Aaron M. Robida, Carlos Murga‐Zamalloa, Ryan A. Wilcox   +11 more
openalex   +1 more source

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino, Cataldo Patruno, Francesca di Vico, Maddalena Napolitano   +3 more
wiley   +1 more source

Brentuximab vedotin as monotherapy or combination therapy for cutaneous peripheral T cell lymphoma - a retrospective study. [PDF]

J Dtsch Dermatol Ges
Glatzel C, Hansen-Abeck I, Booken N, Düll J, Goebeler M, Schummer P, Wobser M.   +6 more
europepmc   +1 more source

Peripheral T-cell lymphoma involving the placenta [PDF]

, 1992
Paul J. Kurtin, Thomas A. Gaffey, Thomas M. Habermann   +2 more
openalex   +1 more source

The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma

British Journal of Haematology, 2017
D. Chihara, M. Fanale, R. Miranda, M. Noorani, J. Westin, L. Nastoupil, F. Hagemeister, L. Fayad, J. Romaguera, F. Samaniego, F. Turturro, H. Lee, S. Neelapu, M. Rodriguez, Michael L. Wang, N. Fowler, R. Davis, L. Medeiros, C. Hosing, Y. Nieto, Y. Oki   +20 more
semanticscholar   +1 more source

Extracellular Vesicle‐Mediated Communication Between Anterior Cruciate Ligament and Bone Marrow Cells Modulates Hamstring Tenocyte Behavior and Apoptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Following anterior cruciate ligament (ACL) reconstruction, enhancing hamstring tenocyte activity and minimizing apoptosis are critical for preventing graft failure and promoting ligamentization. This study investigated the therapeutic potential of extracellular vesicles (EVs) derived from a coculture of ACL remnant cells and bone marrow ...
Hon‐Lok Lo, Shih‐Hao Huang, Ting‐Hsuan Dai, Shun‐Cheng Wu, Cheng‐Jung Ho, Cheng‐Chang Lu   +5 more
wiley   +1 more source

Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma. [PDF]

Blood Adv
Iyer S, Mehta-Shah N, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Alpdogan O, Feldman TA, Camus V, Gritti G, Zinzani PL, Belada D, Mayer J, Choi I, Cheong JW, Rustia E, Fenton K, Fanale M, Savage KJ, Horwitz SM.   +22 more
europepmc   +1 more source

Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy

Medicine Bulletin, EarlyView.
ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley   +1 more source

Ruptura esplénica espontánea asociada a linfoma periférico de células T, presentación de un caso y revisión de la literatura: Case presentation and literature review Spontaneous splenic rupture associated with peripheral T-cell lymphoma

, 2010
Carlos Gómez, Rafael Pava, Alejandro Salazar, Nathalia Sanclemente   +3 more
openalex   +1 more source

Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.

Journal of Clinical Oncology, 2016
S. Adams, P. Newcomb, A. Shustov
semanticscholar   +1 more source